Brief: Enteris Biopharma Announces Successful Completion Of Phase 1 Clinical Trial Of Optimized Peptelligence Oral Leuprolide

SWK Holdings

04/10/2021 13:50

Oct 4 (Reuters) - SWK Holdings Corp  SWKH.O :
    * ENTERIS BIOPHARMA ANNOUNCES SUCCESSFUL COMPLETION OF PHASE
1
CLINICAL TRIAL OF OPTIMIZED PEPTELLIGENCE ORAL LEUPROLIDE

Source text for Eikon:  ID:nPn5hcV3sa 
Further company coverage:  SWKH.O 

 ((Reuters.Briefs@thomsonreuters.com;))